|
|
|
System or Method Share |
|
Each
manufacturers share of systems by model or methods
used for testing each analyte
|
|
Site
Penetration Share |
|
Each
manufacturers share of sites using each system by
model or method for testing each analyte
|
|
Average Number of Systems per Site |
|
Average
number of systems/methods used per site for testing
each analyte
|
|
Total Sites and Installed Base of Systems |
|
Total number of sites in the database and the total
instruments in each relevant market segment by
manufacturer brand and model in use
|
|
Share
Change of Systems/Methods |
|
Site and
analyte share position compared to prior 6 months
|
|
Volume Share by Analyte |
|
Pilot
data available in 2012
|
|
Volume Share Change by Analyte |
|
Pilot
data available in 2012
|
|
Six Month Volume Change by Analyte |
|
Pilot
data available in 2012
|
|
|
|
Allergy |
|
Immunoglobulin E
|
|
Anemia Related / Vitamins |
|
Adrenocorticotropic hormone B-type natriuretic
peptide/NT-pro BNP CK-MB activity CK-MB
(quantitative) High-sensitivity C-reactive protein
Homocysteine Myoglobin Troponin I / Troponin T
|
|
Toxicology |
|
Acetaminophen Amitriptyline Desipramine
Homovanillic acid Imipramine, Nortriptyline
Salicylate, Tricyclics (total)
|
|
Fertility/Pregnancy Hormones and Proteins |
|
Dehydro-epiandrosterone sulphate Dimeric inhibin A
Estradiol Estriol unconjugated
Follicle-stimulating hormone Human chorionic
gonadotropin (qualitative) Human chorionic
gonadotropin (quantitative) Luteinizing hormone
Progesterone Prolactin Sex hormone-binding
globulin Testosterone Androstenedione
|
|
Individual and Specified Hormones/Proteins |
|
1,25
Dihydroxy vitamin D 17-Hydroxyprogesterone 25-OH
vitamin D Aldosterone Cortisol Cortisol
(urinary free) C-Peptide, Gastrin, Human growth
hormone Insulin N-Telopeptide Parathyroid
hormone Procalcitonin
|
|
Rheumatoid/Infammatory Disease Markers |
|
Alpha-1
antitrypsin Anti-streptolysin O (qualitative)
Anti-streptolysin O (semi-quantitative) Anti-streptolysin
O (quantitative) C-Reactive Protein (qualitative)
C-Reactive Protein (quantitative) Rheumatoid
factor
|
|
Specific Proteins |
|
Apolipoprotein A1 Apolipoprotein B Cystatin C
Bence Jones Protein Haptaglobulin Immunoglobulin
A Immunoglobulin G Immunoglobulin G (CSF)
Immunoglobulin M Lipoprotein (a) Prealbumin
Transferrin
|
|
Therapeutic Drug Monitoring |
|
Amikacin
Caffeine Carbamazepine Cyclosporine Digoxin
Gentamicin Lidocaine Methotrexate
Mycophenolic acid N-acetylprocainamide
Phenobarbital Phenytoin free Phenytoin total
Primidone Procainamide Quinidine Sirolimus (rapamycin)
Tacrolimus Theophylline Tobramycin Valproic
acid Valproic acid free Vancomycin
|
|
Thyroid Function Hormones |
|
T4 free
(thyroxine free) T4 total (thyroxine total)
Thyroglobulin Thyroid-stimulating hormone
Triiodothyronine free (T3) Triiodothyronine total
(T3) Triiodothyronine uptake (T3)
|
|
Tumor
Markers |
|
5-Hydroxyindoleacetic acid Alpha-fetoprotein
Beta-2-microglobulin CA 125 CA 15-3 CA 19-9
CA 27-29 Carcinoembryonic antigen Norepinephrine
Normetanephrine Prostate-specific antigen, free
Prostate-specific antigen, total
Vanillylmandelic acid
|